Capillary Technologies India Limited has submitted its Monitoring Agency Report for the quarter ended December 31, 2025, concerning the utilization of its Initial Public Offer (IPO) proceeds. The report, dated February 06, 2026, was issued by CRISIL Ratings Limited, the appointed Monitoring Agency. The Audit Committee of Capillary Technologies reviewed the report on February 06, 2026, and it will be made available on the company's website. The IPO, which had a size of ₹3,450.00 million (345 crore), involved utilization of proceeds for cloud infrastructure costs, investment in research, development, and product enhancement, purchase of computer systems, and funding inorganic growth and general corporate purposes. The report indicates that as of December 31, 2025, a total of ₹3,395.81 million (339.58 crore) of the gross proceeds had been deployed or remained in accounts, with ₹3,395.81 million (339.58 crore) of the net proceeds utilized or accounted for against the total net proceeds of ₹3,229.08 million (322.91 crore). Specifically, ₹1,430.00 million (143 crore) was allocated for cloud infrastructure, ₹715.81 million (71.58 crore) for R&D, ₹103.42 million (10.34 crore) for computer systems, and ₹979.85 million (97.98 crore) for inorganic growth and general corporate purposes. A small amount of ₹0.13 million (0.013 crore) was utilized for general corporate purposes during the quarter. Issue expenses accounted for ₹220.92 million (22.09 crore), with ₹54.06 million (5.41 crore) utilized during the quarter, leaving ₹166.86 million (16.69 crore) unutilized. The unutilized proceeds, totaling ₹3,395.81 million (339.58 crore), are primarily held in fixed deposits with various banks, maturing between January 2026 and December 2026. A balance of ₹98.45 million (9.85 crore) remains in the Public Issue Account and ₹68.46 million (6.85 crore) in the Monitoring Account, with a minor portion of the latter pertaining to net proceeds.
